Patents by Inventor Patrick M. Gaffney

Patrick M. Gaffney has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200339997
    Abstract: The present invention includes a method of treating a bone disease caused by a intracellular protein trafficking defect comprising: identifying a subject having the bone disease caused by the intracellular protein trafficking defect in a membrane bound transcription factor peptidase, site 1 (MBTPS1) gene; and providing the subject with an effective amount of a composition that bypasses or corrects a defect in MBTPS1 gene expression, gene splicing, or corrects protein trafficking defects in the endoplasmic reticulum and to the lysosome.
    Type: Application
    Filed: October 23, 2018
    Publication date: October 29, 2020
    Inventors: Yuji Kondo, Jianxin Fu, Hua Wang, Klaas Wierenga, Patrick M. Gaffney, Lijun Xia
  • Patent number: 8008013
    Abstract: The present invention provides methods for the prediction and diagnosis of autoimmune diseases, including Systemic Lupus Erythematosus, using single nucleotide polymorphism in TNFAIP3 (A20).
    Type: Grant
    Filed: November 17, 2008
    Date of Patent: August 30, 2011
    Assignee: Oklahoma Medical Research Foundation
    Inventors: Patrick M. Gaffney, Kathy L. Moser
  • Publication number: 20090130683
    Abstract: The present invention provides methods for the prediction and diagnosis of autoimmune diseases, including Systemic Lupus Erythematosus, using single nucleotide polymorphism in TNFAIP3 (A20).
    Type: Application
    Filed: November 17, 2008
    Publication date: May 21, 2009
    Inventors: Patrick M. Gaffney, Kathy L. Moser